MediPharm Labs Announces CEO Transition: David Pidduck to Step Down; CFO Greg Hunter Appointed Interim CEO

MediPharm Labs Announces CEO Transition: David Pidduck to Step Down; CFO Greg Hunter Appointed ...

TORONTO, Jan. 19, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, today announced that David Pidduck will be stepping down from his role as…

MediPharm Labs Announces CEO Transition: David Pidduck to Step Down; CFO Greg Hunter Appointed Interim CEO

MediPharm Labs Announces CEO Transition: David Pidduck to Step Down; CFO Greg Hunter Appointed Interim CEO...

MediPharm appoints Greg Hunter interim CEO - BioTuesdays

MediPharm Labs (TSX: LABS; OTCQB: MEDIF; FSE: MLZ) has announced that its CEO, David Pidduck, will step down from his role as of January 23, 2026, and that Greg Hunter, the company’s CFO, has been appointed interim CEO. Mr. Hunter will continue to serve as CFO while leading the company as interim CEO. In a statement, Chris Taves, chair of the board, commented, “On behalf of the Board and the entire MediPharm Labs team, I want to thank David for …

MediPharm Labs announces CEO transition as David Pidduck steps down

MediPharm Labs (TSX:LABS) CEO David Pidduck will step down on January 23, 2026, and will remain on the Board to support the transition CFO Greg Hunter has been appointed Interim CEO, continuing his CFO duties while the Board evaluates long‑term leadership plans Pidduck and Hunter are credited with strengthening MediPharm’s operations, including restructuring efforts, improved profitability, and the integration of VIVO Cannabis Inc. MediPharm Lab…

MediPharm Labs Announces CEO David Pidduck To Step Down, Greg Hunter Named Interim CEO

TORONTO — MediPharm Labs Corp., a pharmaceutical company specializing in precision-based cannabinoids, announced on Jan. 19 that David Pidduck will be stepping down from his role as the company’s Chief Executive Officer, effective Jan. 23, 2026. The board of directors has appointed Greg Hunter, the company’s Chief Financial Officer, as Interim Chief Executive Officer, while it evaluates its long‑term leadership plans. Hunter will continue to ser…

CFO Greg Hunter Appointed Interim CEO at MediPharm Labs

TORONTO — David Pidduck will step down from his role as MediPharm Labs Corp.’s chief executive officer effective January 23. The Board of Directors has appointed Greg Hunter, the company’s chief financial officer interim chief executive officer while it evaluates long‑term leadership plans. Hunter will continue to serve as CFO. Pidduck will continue to serve on the board to ensure a seamless transition. Since assuming the CFO role in February 20…